The global Fish Skin Disease Market, which includes treatments for fish diseases, was valued at US$ 1.72 Billion in 2022 and is expected to grow at a compound annual growth rate (CAGR) of 7.1% to reach US$ 2.98 Billion by end of 2030. The growth of the market is driven by factors such as the increasing demand for fish as a source of protein, the rising prevalence of aquatic animal diseases, and the growing aquaculture industry. The market for fish health treatments includes products such as vaccines, antibiotics, parasiticides, and other therapies used to treat various fish diseases, including those affecting the skin.
Global Fish Skin Disease Market Regional Insights
- Asia Pacific: The Asia Pacific region is expected to witness significant growth in the fish health market, driven by the increasing demand for fish as a source of protein and the growing aquaculture industry. Additionally, the region is home to many fish farms and fisheries, which may be more susceptible to outbreaks of fish skin diseases due to crowded living conditions and environmental factors. Asia Pacific holds around 20% of the market share.
- North America: The North American market for fish health treatments is expected to grow due to the increasing demand for fish as a healthy food source and the rising prevalence of fish skin diseases in the region. The region is home to several species of fish, such as salmon and trout, that are particularly susceptible to skin diseases, including bacterial infections and parasites. North America accounts for approximately 40% of the market share.
- Europe: The European market for fish health treatments is also expected to grow, driven by the increasing demand for fish as a source of protein and the growth of the aquaculture industry in the region. Additionally, several regions in Europe are known for their fishing industries and may experience a higher prevalence of fish skin diseases. This region holds a substantial percentage of the market share, accounting for approximately 30%.
Figure 1. Global Fish Skin Disease Market, By Region

Global Fish Skin Disease Market Drivers:
The fish skin disease market is driven by several factors, including:
- Increasing demand for fish as a source of protein: The global demand for fish as a source of protein is increasing, driven by factors such as population growth, changing dietary habits, and health concerns. As the demand for fish increases, so does the need for effective treatments for fish skin diseases that can impact fish production.
- Growing aquaculture industry: The global aquaculture industry is growing, driven by increasing demand for fish and seafood and the declining wild fish stocks. As the aquaculture industry grows, the incidence of fish skin diseases may increase due to crowded living conditions and other environmental factors, leading to higher demand for treatments.
- Rising prevalence of fish skin diseases: The prevalence of fish skin diseases is increasing globally, driven by factors such as environmental pollution, changes in water temperature, and the movement of fish between regions. This trend is expected to drive demand for treatments for fish skin diseases.
- Government initiatives and funding: Governments and other organizations are increasing their focus on the development of sustainable aquaculture practices, including the prevention and treatment of fish skin diseases. This focus is leading to increased funding for research and development of new treatments and therapies for fish skin diseases.
Global Fish Skin Disease Market Opportunities:
- Increasing demand for natural and sustainable treatments: There is growing demand for natural and sustainable treatments for fish skin diseases that can minimize the environmental impact of aquaculture practices. This presents an opportunity for companies to develop new and innovative treatments that are effective, sustainable, and environmentally friendly.
- Expansion of the aquaculture industry: The expansion of the aquaculture industry in different regions presents an opportunity for companies to expand their reach and develop new markets for their products. As more regions invest in aquaculture practices, there will be an increasing demand for treatments for fish skin diseases.
- Increasing focus on preventive measures: There is a growing focus on preventive measures to reduce the incidence and impact of fish skin diseases, such as improving water quality, implementing biosecurity measures, and developing new vaccines. This presents an opportunity for companies to develop new products and services that can help prevent the onset of fish skin diseases.
- Technological advancements: The development of new technologies, such as gene editing and molecular diagnostics, presents an opportunity for companies to develop new and more effective treatments for fish skin diseases. These technologies can help to target specific pathogens and develop more precise treatments.
Global Fish Skin Disease Market Trends:
- Increasing use of vaccines: Vaccines are becoming increasingly popular as a preventative measure against fish skin diseases. As a result, there is growing demand for vaccines that can provide immunity against a broad range of pathogens.
- Development of new antibiotic alternatives: Due to concerns about the overuse of antibiotics in the aquaculture industry, there is increasing focus on developing alternative treatments for fish skin diseases. This includes the development of probiotics, phage therapy, and other natural treatments.
- Growing interest in precision medicine: There is increasing interest in developing precision medicine solutions for fish skin diseases. This includes the use of molecular diagnostics to identify specific pathogens and develop targeted treatments.
- Integration of technology: The use of technology, including automation and artificial intelligence, is becoming increasingly common in the fish health industry. This includes the development of new diagnostic tools, monitoring systems, and other technologies that can improve the efficiency and effectiveness of fish health treatments.
Fish Skin Disease Market Report Coverage
Report Coverage |
Details |
Base Year: |
2022 |
Market Size in 2022: |
US$ 1.72 Bn |
Historical Data for: |
2017 to 2021 |
Forecast Period: |
2023 - 2030 |
Forecast Period 2023 to 2030 CAGR: |
7.1% |
2030 Value Projection: |
US$ 2.98 Bn |
Geographies covered: |
- North America: U.S. and Canada
- Europe: Germany, U.K., Spain, France, Italy, Russia, and Rest of Europe
- Asia Pacific: China, India, Japan, Australia, South Korea, ASEAN, and Rest of Asia Pacific
- Latin America: Brazil, Argentina, Mexico, and Rest of Latin America
- Middle East & Africa: GCC Countries, Israel, South Africa, North Africa, and Central Africa and Rest of Middle East
|
Segments covered: |
- By Type of disease: Bacterial Infections, Parasitic Infections, Viral Infections, Fungal Infections
- By Treatment type: Antibiotics, Vaccines, Probiotics, Phage Therapy, Other Natural Treatments
- By Fish species: Talmon, Trout, Tilapia, Catfish, Others
- By End user: Aquaculture Producers, Fisheries, Other organizations involved in fish production
|
Companies covered: |
Zoetis Inc., Elanco Animal Health, MSD Animal Health, Benchmark Holdings, Phibro Animal Health Corporation, Intervet Inc., Norvartis, Merck Animal Health, Novartis AG, Pharmaq AS, AquaBounty Technologies, Alltech, Skretting, Nutreco, Biomin
|
Growth Drivers: |
- Increasing demand for fish as a source of protein
- Growing aquaculture industry
- Rising prevalence of fish skin diseases
- Government initiatives and funding
|
Restraints & Challenges: |
- Regulatory Hurdles
- High Cost Of Treatments
- Limited Availability Of Treatments
|
Global Fish Skin Disease Market Restraints:
- Regulatory hurdles: The approval process for new treatments and therapies can be lengthy and complex, and regulatory hurdles can pose a significant challenge for companies developing new treatments for fish skin diseases. This can limit the ability of companies to bring new products to market and slow the pace of innovation.
- High cost of treatments: The cost of treatments for fish skin diseases can be high, particularly for newer and more advanced treatments. This can limit the ability of smaller companies to enter the market and make it difficult for aquaculture producers to afford the treatments they need.
- Limited availability of treatments: Some treatments for fish skin diseases may not be widely available, particularly in smaller or less developed markets. This can limit the ability of companies to reach new customers and limit the growth of the market.
Figure 2. Global Fish Skin Disease Market, By Type of disease

Global Fish Skin Disease Market Recent Developments
New product launches
- In 2021, MSD Animal Health launched a new vaccine called AQUAVAC® PD3 which provides protection against Piscine orthoreovirus (PRV) and salmonid alphavirus subtype 3 (SAV3) in salmon.
- In 2020, Phibro Animal Health Corporation launched V-PLEX™ LINCOMIX, an antibiotic water-soluble powder used to treat bacterial infections, including those that cause fish skin diseases, in a variety of fish species.
- In 2019, Aqua-PVAXx™, a vaccine developed by AquaBounty Technologies, received approval from the FDA for use in preventing diseases caused by Aeromonas salmonicida in farmed Atlantic salmon.
Acquisition and partnerships:
- In 2020, Elanco Animal Health acquired the animal health business of Bayer AG, which included a portfolio of aquaculture products, such as antibiotics and vaccines for fish health.
- In 2019, Benchmark Holdings acquired INVE Aquaculture, a leading provider of health and nutrition solutions for fish and shrimp, in a deal worth €342 million.
- In 2018, MSD Animal Health acquired Vaki, a leading developer of equipment for fish health management, to expand its portfolio of solutions for the aquaculture industry.
Global Fish Skin Disease Market Top 15 Key Player
- Zoetis Inc.
- Elanco Animal Health
- MSD Animal Health
- Benchmark Holdings
- Phibro Animal Health Corporation
- Intervet Inc.
- Norvartis
- Merck Animal Health
- Novartis AG
- Pharmaq AS
- AquaBounty Technologies
- Alltech
- Skretting
- Nutreco
- Biomin
Ichthyosis is a medical condition that causes widespread and persistent thick, dry, "fish-scale" skin. It is a group of skin disorders that lead to dry and itchy skin that appears scaly, rough, and red. The symptoms can range from mild to severe. Ichthyosis can affect only the skin, but some forms of the disease can affect internal organs as well. There are more than 20 different types of ichthyosis. Some types are inherited at the birth and other types are acquired during adulthood. The treatment helps reduce the redness of the skin, thickness of the scales, and itching.
Market Dynamics:
Rise in burden of fish skin disease, rise in awareness among people, increase in demand for safe, effective treatments & therapies, and introduction of novel treatments/therapies by market players are major factors expected to propel growth of the global fish skin disease market.
For instance, in April 2023, Kerecis announced the launch of the MariGen Shield, a solution that combines the company’s fish-skin graft and a silicone contact layer to treat chronic and complex wounds. The silicone contact layer anchors the round graft in position, help safeguard granulating wound and the fish-skin graft following the application of a protective cover dressing.
Moreover, in October 2021, Kerecis received the Food and Drug Administration (FDA) marketing authorisation for Omega3 SurgiBind. It is an implantable fish-skin graft intended for use in plastic and reconstructive surgery. It is indicated for strengthening weak soft tissue in patients who require soft tissue repair, or reinforcement in plastic or reconstructive surgery.
Key features of the study:
- This report provides in-depth analysis of the global fish skin disease market, and provides market size (US$ Billion) and compound annual growth rate (CAGR%) for the forecast period (2023–2030), considering 2022 as the base year.
- It elucidates potential revenue opportunities across different segments and explains attractive investment proposition matrices for this market.
- This study also provides key insights about market drivers, restraints, opportunities, new product launches or approval, market trends, regional outlook, and competitive strategies adopted by key players.
- It profiles key players in the global fish skin disease market based on the following parameters such as company highlights, products portfolio, key highlights, financial performance, and strategies.
- Key companies covered as a part of this study include Zoetis Inc., Biomin, Nutreco, Skretting, Alltech, AquaBounty Technologies, Pharmaq AS, Novartis AG, Merck Animal Health, Novartis, Intervet Inc., Benchmark Holdings, MSD Animal Health, Elanco Animal Health, and Phibro Animal Health Corporation, among others.
- Insights from this report would allow marketers and the management authorities of the companies to make informed decisions regarding their future product launches, type up-gradation, market expansion, and marketing tactics.
- The global fish skin disease market report caters to various stakeholders in this industry including investors, suppliers, product manufacturers, distributors, new entrants, and financial analysts.
- Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the global fish skin disease market.
Detailed Segmentation:
- Global Fish Skin Disease Market, Type of Disease:
- Bacterial Infections
- Parasitic Infections
- Viral Infections
- Fungal Infections
- Global Fish Skin Disease Market, By Treatment Type:
- Antibiotics
- Vaccines
- Probiotics
- Phage Therapy
- Other Natural Treatments
- Global Fish Skin Disease Market, By Fish Species:
- Salmon
- Trout
- Tilapia
- Catfish
- Others
- Global Fish Skin Disease Market, By End User:
- Aquaculture Producers
- Fisheries
- Other Organizations Involved in Fish Production
- Global Fish Skin Disease Market, By Geography:
- North America
- Europe
- Asia Pacific
- Latin America
- Middle East and Africa
- Company Profiles:
- Zoetis Inc.
- Biomin
- Nutreco
- Skretting
- Alltech
- AquaBounty Technologies
- Pharmaq AS
- Novartis AG
- Merck Animal Health
- Novartis
- Intervet Inc.
- Benchmark Holdings
- MSD Animal Health
- Elanco Animal Health
- Phibro Animal Health Corporation